普華和順(01358.HK):向Biomedical Treasure完全出售375萬股CBPO股份
格隆匯 1 月 7日丨普華和順(01358.HK)發佈公吿,管理股份購買協議I所載的所有先決條件均已獲達成,且管理出售事項I交割2021年1月6日(美國東部時間)根據管理股份購買協議I的條款及條件落實,而公司已根據該協議向Biomedical Treasure完全出售375萬股CBPO股份。
於上述管理出售事項I交割以及早前於2020年12月30日(美國東部時間)落實的CITIC出售事項及管理出售事項II的交割後,實際出售事項已透過交易文件及其項下擬進行的交易(包括出售事項)落實,因此,透過提供合併事項投票承諾及其項下促進的交易(包括現金兑付)進行的實際出售事項將不會落實。緊隨管理出售事項I交割後,公司不再持有任何CBPO股份且已不再為財團成員。
此外,特別股息已於管理出售事項I交割後成為無條件,並將根據公司日期為2020年12月29日的公吿所載的安排派付予合資格股東。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.